Auriculocondylar syndrome 2 results from the dominant-negative action of PLCB4 variants.
Kanai, Stanley M, Caleb Heffner, Timothy C Cox, Michael L Cunningham, Francisco A Perez, Aaron M Bauer, Philip Reigan, Cristan Carter, Stephen A Murray, and David E Clouthier. 2022. “Auriculocondylar Syndrome 2 Results from the Dominant-Negative Action of PLCB4 Variants.”. Disease Models & Mechanisms 15 (4).